Psychemedics Stock Probability of Future Stock Price Finishing Under 3.77
| PMD Stock | USD 2.33 0.01 0.43% |
Psychemedics |
Psychemedics Target Price Odds to finish below 3.77
The tendency of Psychemedics Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay under $ 3.77 after 90 days |
| 2.33 | 90 days | 3.77 | close to 99 |
Based on a normal probability distribution, the odds of Psychemedics to stay under $ 3.77 after 90 days from now is close to 99 (This Psychemedics probability density function shows the probability of Psychemedics Stock to fall within a particular range of prices over 90 days) . Probability of Psychemedics price to stay between its current price of $ 2.33 and $ 3.77 at the end of the 90-day period is about 29.34 .
Considering the 90-day investment horizon Psychemedics has a beta of 0.084 indicating as returns on the market go up, Psychemedics average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Psychemedics will be expected to be much smaller as well. Additionally Psychemedics has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Psychemedics Price Density |
| Price |
Predictive Modules for Psychemedics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Psychemedics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Psychemedics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Psychemedics is not an exception. The market had few large corrections towards the Psychemedics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Psychemedics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Psychemedics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.0057 | |
β | Beta against Dow Jones | 0.08 | |
σ | Overall volatility | 0.02 | |
Ir | Information ratio | -0.19 |
Psychemedics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Psychemedics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Psychemedics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| The company reported the last year's revenue of 22.1 M. Reported Net Loss for the year was (4.15 M) with profit before taxes, overhead, and interest of 9.29 M. | |
| Psychemedics has about 1.79 M in cash with (1.48 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.32. | |
| Psychemedics has a poor financial position based on the latest SEC disclosures | |
| Roughly 23.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from accesswire.com: PMD Device Solutions Announces Delay to Q3 2024 Quarterly Report |
Psychemedics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Psychemedics Stock often depends not only on the future outlook of the current and potential Psychemedics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Psychemedics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 5.7 M | |
| Cash And Short Term Investments | 2 M |
Psychemedics Technical Analysis
Psychemedics' future price can be derived by breaking down and analyzing its technical indicators over time. Psychemedics Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Psychemedics. In general, you should focus on analyzing Psychemedics Stock price patterns and their correlations with different microeconomic environments and drivers.
Psychemedics Predictive Forecast Models
Psychemedics' time-series forecasting models is one of many Psychemedics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Psychemedics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Psychemedics
Checking the ongoing alerts about Psychemedics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Psychemedics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| The company reported the last year's revenue of 22.1 M. Reported Net Loss for the year was (4.15 M) with profit before taxes, overhead, and interest of 9.29 M. | |
| Psychemedics has about 1.79 M in cash with (1.48 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.32. | |
| Psychemedics has a poor financial position based on the latest SEC disclosures | |
| Roughly 23.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from accesswire.com: PMD Device Solutions Announces Delay to Q3 2024 Quarterly Report |
Check out Psychemedics Backtesting, Psychemedics Valuation, Psychemedics Correlation, Psychemedics Hype Analysis, Psychemedics Volatility, Psychemedics History as well as Psychemedics Performance. For information on how to trade Psychemedics Stock refer to our How to Trade Psychemedics Stock guide.You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Psychemedics. If investors know Psychemedics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Psychemedics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.30) | Earnings Share (0.51) | Revenue Per Share 3.586 | Quarterly Revenue Growth (0.15) | Return On Assets (0.16) |
The market value of Psychemedics is measured differently than its book value, which is the value of Psychemedics that is recorded on the company's balance sheet. Investors also form their own opinion of Psychemedics' value that differs from its market value or its book value, called intrinsic value, which is Psychemedics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Psychemedics' market value can be influenced by many factors that don't directly affect Psychemedics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Psychemedics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Psychemedics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Psychemedics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.